New hope for advanced cancer: experimental drug CR-001 enters human trials
NCT ID NCT07335497
First seen Jan 17, 2026 · Last updated Jun 17, 2026 · Updated 22 times
Summary
This study tests a new drug called CR-001 in adults with advanced solid tumors that have spread. The goal is to find the safest dose and see if it can shrink tumors. About 290 people will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Study Site
RECRUITINGLos Angeles, California, 90033, United States
-
Clinical Study Site
RECRUITINGDenver, Colorado, 80218, United States
-
Clinical Study Site
RECRUITINGOrlando, Florida, 32827, United States
-
Clinical Study Site
RECRUITINGSarasota, Florida, 34236, United States
-
Clinical Study Site
RECRUITINGDetroit, Michigan, 48201, United States
-
Clinical Study Site
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
Clinical Study Site
RECRUITINGNew York, New York, 10029, United States
-
Clinical Study Site
RECRUITINGColumbus, Ohio, 43210, United States
-
Clinical Study Site
RECRUITINGNashville, Tennessee, 37203, United States
-
Clinical Study Site
RECRUITINGDallas, Texas, 75230, United States
-
Clinical Study Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Clinical Study Site
RECRUITINGWest Valley City, Utah, 84119, United States
-
Clinical Study Site
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Clinical Study Site
RECRUITINGCluj-Napoca, Cluj, 400015, Romania
-
Clinical Study Site
RECRUITINGSeoul, Seoul, 03080, South Korea
-
Clinical Study Site
RECRUITINGSeoul, Seoul, 03722, South Korea
-
Clinical Study Site
RECRUITINGSeoul, Seoul, 06351, South Korea
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.